Anti-coagulation in the diagnosis and treatment of patients with ovarian malignancies
XING Yi-chun
WU Miao-fang
LIN Zhong-qiu
Abstract：Patients with ovarian cancer are prone to venous thromboembolism(VTE).The risk of VTE for those ovarian cancer patients who receive debulking surgeries would persist until 4 weeks after surgery.Meanwhile,chemotherapy and bevacizumab may in-crease the risk of VTE.During the process of diagnosis and treatment of ovarian cancer,predictive tools such as Caprini score,G-Caprini score and Khorana score can be used to assess the risk of VTE,so that the gy-necologic oncologists can perform stratified manage-ment,and utilize the clinical methods such as D-dimer and ultrasound to screen,find and manage VTE as early as possible,in order to reduce the harm of VTE and improve the prognosis of ovarian cancer patients.
Keywords：ovarian canervenous thromboembo-lismprophylaxisanticoagulation
Publication Date：2024-11-02
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 1061-1065 )